IMNN as of Nov 3 · 20:56 ET
IMNNNasdaqPharmaceutical Preparations

Imunon, Inc. · Brief

Next report

8 days

Nov 12 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26—▼−1.23%—
quarterimplied−5%0+5%realized×
Q2 FY26—▼−1.23%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull1

18institutional managers reporting a position13F · Jun 30 '26

Bear2 of 3

4managers holding most of reported position value13F · Jun 30 '26
4 of 12largest reporting managers that cut their stake in the quarter13F · Jun 30 '26
AI captions · Oct 11 '26once per report · top 2 per case

Linked exposure

IMNN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 218-KMaterial agreement: Asset Purchase Agreement with VoxelDox Therapeutics, Inc.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.